Today is the perfect time to invest in yourself

Typically included in a transparent flat plan Asynchronous or synchronous clinician review of your intake The prescribed compounded medication for the billing period, where clinically appropriate Standard shipping from the partner pharmacy Ongoing message-based clinician access for dose questions and side-effect concerns Dose adjustments during titration without a new consult fee Cancellation handled through a documented, self-service or support-assisted process What is frequently not included (verify before paying) Laboratory work, if a clinician requires baseline or follow-up labs FDA-approved brand medications such as Wegovy or Zepbound, which are priced separately and subject to insurance Expedited or cold-chain upgraded shipping, where offered Treatment of conditions outside the weight-management or metabolic scope Any third-party telehealth visit fees billed outside the platform Refunds for product already shipped, which most compounding pharmacies cannot accept back for sterility reasons Editorial note: A flat price is only meaningful if the total out-of-pocket cost across the full titration schedule is predictable

The agency says it has only limited safety information for the proposed methods of administration and cannot determine whether the compound would harm humans
Today, PT-141 is FDA-approved for premenopausal women with hypoactive sexual desire disorder (HSDD), a condition marked by a persistent lack of sexual desire that causes distress or strain in relationships
that responsibility lies with the FDA
Recent observational studies and secondary trial analyses suggest GLP-1 agonists may reduce abdominal pain frequency, improve stool consistency, and decrease bloating in some IBS patientsparticularly those who are overweight